Back
SPDR® S&P 400 Mid Cap Value ETF Vs. Viking Therapeutics Industry Stock Comparison
Buy
58
MDYV
SPDR® S&P 400 Mid Cap Value ETF
Last Price:
78.93
Seasonality Move:
4.7%
Buy
53
VKTX
Viking Therapeutics
Last Price:
64.95
Seasonality Move:
34.33%
Buy
58
SPDR® S&P 400 Mid Cap Value ETF (MDYV)
is a Buy
Is SPDR® S&P 400 Mid Cap Value ETF a Buy, Sell or Hold?
- The current SPDR® S&P 400 Mid Cap Value ETF [MDYV] share price is $79.28. The Score for MDYV is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- MDYV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $64.96. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDYV Stock Price Chart
What is SPDR® S&P 400 Mid Cap Value ETF's stock price today?
-
The SPDR® S&P 400 Mid Cap Value ETF share price today is $79.28
The current trend is moderately bullish and MDYV is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $64.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDYV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 58.32 | Buy |
| Chaikin Money Flow: | 31009 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.59 - 79.41) | Buy |
| Bollinger Bands (100): | (73.36 - 77.96) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 54.51 | Buy |
| Chaikin Money Flow: | 1135470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.05 - 66.47) | Buy |
| Bollinger Bands (100): | (52.64 - 64.98) | Buy |
MDYV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.96 | Buy |
| 20-day SMA: | 78.23 | Buy |
| 50-day SMA: | 77.17 | Buy |
| 200-day SMA: | 74.17 | Buy |
| 8-day EMA: | 78.91 | Buy |
| 20-day EMA: | 78.44 | Buy |
| 50-day EMA: | 77.32 | Buy |
| 200-day EMA: | 74.05 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.29 | Buy |
| 20-day SMA: | 63.32 | Buy |
| 50-day SMA: | 60.76 | Buy |
| 200-day SMA: | 55.03 | Buy |
| 8-day EMA: | 63.88 | Buy |
| 20-day EMA: | 63.16 | Buy |
| 50-day EMA: | 61.34 | Buy |
| 200-day EMA: | 52.6 | Buy |
SPDR® S&P 400 Mid Cap Value ETF Earnings Growth & MDYV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
SPDR® S&P 400 Mid Cap Value ETF Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||